Skip to main content
SpringerLink
Log in

New Clinical Trials in Acute and Recurrent Pericarditis

  • Pericardial Disease (AL Klein)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Clinical trials in the last decade have improved the quality of evidence to support preventive medical strategies to reduce the risk of recurrences after pericarditis. There are essentially three main strategies: (1) to use full anti-inflammatory doses for the treatment of each attack of pericarditis till symptoms resolution and normalization of markers of inflammation (i.e., C-reactive protein); (2) to limit the use of corticosteroids and, if used, to use low to moderate doses (i.e., prednisone 0.2 to 0.5 mg/kg/day or equivalent) followed by slow tapering; and (3) to add colchicine to improve the response to conventional anti-inflammatory therapies and reduce the risk of recurrences. Recommended regimens include weight-adjusted doses (i.e., 0.5–0.6 mg twice daily for patients weighing >70 kg or 0.5–0.6 mg once daily for patients weighing ≤70 kg for 3 months for acute pericarditis and 6 months for recurrences) without a loading dose to improve patients’ compliance. Using these doses and appropriate selection of patients (e.g. to avoid severe renal impairment or adjust doses according to comorbid conditions and concomitant therapies), the drug is well tolerated, may cause reversible gastrointestinal intolerance (mainly diarrhea) in about 8 to 10 % of cases but has no severe side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Imazio M, Cecchi E, Demichelis B, et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart. 2008;94(4):498–501.

    Article  CAS  PubMed  Google Scholar 

  2. Kytö V, Sipilä J, Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation. 2014 Sep 9.

  3. Imazio M, Brucato A, Mayosi BM, et al. Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis. J Cardiovasc Med (Hagerstown). 2010;11(10):712–22.

    Google Scholar 

  4. Imazio M. Pericardial involvement in systemic inflammatory diseases. Heart. 2011;97(22):1882–92.

    Article  PubMed  Google Scholar 

  5. Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol. 2012;27(3):308–17.

    Article  PubMed  Google Scholar 

  6. Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y. Controversial issues in the management of pericardial diseases. Circulation. 2010;121(7):916–28.

    Article  PubMed  Google Scholar 

  7. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112(23):3608–16.

    Article  PubMed  Google Scholar 

  8. Mayosi BM. Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart. 2007;93(10):1176–83.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ntsekhe M, Mayosi BM. Tuberculous pericarditis with and without HIV. Heart Fail Rev. 2013;18(3):367–73.

    Article  PubMed  Google Scholar 

  10. Lotrionte M, Biondi-Zoccai G, Imazio M, et al. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J. 2010;160(4):662–70.

    Article  CAS  PubMed  Google Scholar 

  11. Imazio M, Adler Y. Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis. Heart Fail Rev. 2013;18(3):355–60.

    Article  CAS  PubMed  Google Scholar 

  12. Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008;118(6):667–71.

    Article  CAS  PubMed  Google Scholar 

  13. Imazio M. Idiopathic recurrent pericarditis as an immune-mediated disease: current insights into pathogenesis and emerging treatment options. Expert Rev Clin Immunol. 2014 Oct 11:1–6. [Epub ahead of print].

  14. Shabetai R. Corticosteroids for recurrent pericarditis: on the road to evidence-based medicine. Circulation. 2008;118(6):612–3.

    Article  PubMed  Google Scholar 

  15. Imazio M, Brucato A, Belli R, Forno D, Ferro S, Trinchero R, Adler Y. Colchicine for the prevention of pericarditis: what we know and what we do not know in 2014—systematic review and meta-analysis. J Cardiovasc Med Hagerstown). 2014 Jul 3. [Epub ahead of print]. First updated systematic review summarizing the efficacy and safety of colchicine for pericarditis prevention.

  16. Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112(13):2012–6.

    Article  CAS  PubMed  Google Scholar 

  17. Imazio M, Bobbio M, Cecchi E, et al. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005;165(17):1987–91.

    Article  CAS  PubMed  Google Scholar 

  18. Imazio M, Trinchero R, Brucato A, et al. COPPS Investigators. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010;31(22):2749–54. First multicenter RCT on the post-operative use of colchicine to prevent the post-pericardiotomy syndrome.

    Article  CAS  PubMed  Google Scholar 

  19. Imazio M, Brucato A, Cemin R, et al. CORP (COlchicine for Recurrent Pericarditis) Investigators. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med. 2011;155(7):409–14. First multicenter RCT on the use of colchicine to prevent recurrent pericarditis in the setting of the first recurrence.

    Article  PubMed  Google Scholar 

  20. Imazio M, Brucato A, Cemin R, et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369(16):1522–8. First multicenter RCT on the use of colchicine to prevent recurrent pericarditis in the setting of the first attack of pericarditis (acute pericarditis).

    Article  CAS  PubMed  Google Scholar 

  21. Imazio M, Belli R, Brucato A, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet. 2014;383(9936):2232–7. First multicenter RCT on the use of colchicine to prevent recurrent pericarditis in the setting of multiple recurrences.

    Article  CAS  PubMed  Google Scholar 

  22. Imazio M, Brucato A, Ferrazzi P, et al. COPPS-2 Investigators. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. JAMA. 2014;312(10):1016–23. First multicenter RCT on the perioperative use of colchicine to prevent the post-pericardiotomy syndrome.

    Article  CAS  PubMed  Google Scholar 

  23. Meurin P et al. POPE 2 abstract presented at 2014 ESC Congress. First multicenter RCT on the post-operative use of colchicine to treat late moderate to large post-operative effusions and prevent cardiac tamponade.

  24. Wechalekar MD, Vinik O, Moi JH, et al. The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors. J Rheumatol Suppl. 2014;92:15–25.

    Article  CAS  PubMed  Google Scholar 

  25. Güil A. Treatment of familial Mediterranean fever: colchicine and beyond. Isr Med Assoc J. 2014;16(5):281–4.

    Google Scholar 

  26. Rodríguez de la Serna A, Guindo Soldevila J, Martí Claramunt V, Bayés de Luna A. Colchicine for recurrent pericarditis. Lancet. 1987;2(8574):1517.

    Article  PubMed  Google Scholar 

  27. Artom G, Koren-Morag N, Spodick DH, et al. Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur Heart J. 2005;26(7):723–7.

    Article  CAS  PubMed  Google Scholar 

  28. Yazigi A, Abou-Charaf LC. Colchicine for recurrent pericarditis in children. Acta Paediatr. 1998;87(5):603–4.

    Article  CAS  PubMed  Google Scholar 

  29. Adler Y, Finkelstein Y, Guindo J, et al. Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation. 1998;97(21):2183–5.

    Article  CAS  PubMed  Google Scholar 

  30. Adler Y, Zandman-Goddard G, Ravid M, et al. Usefulness of colchicine in preventing recurrences of pericarditis. Am J Cardiol. 1994;73(12):916–7.

    Article  CAS  PubMed  Google Scholar 

  31. Millaire A, de Groote P, Decoulx E, Goullard L, Ducloux G. Treatment of recurrent pericarditis with colchicine. Eur Heart J. 1994;15(1):120–4.

    CAS  PubMed  Google Scholar 

  32. Millaire A, Ducloux G. Treatment of recurrent pericarditis with colchicine before using corticosteroids. Eur Heart J. 1993;14(10):1438.

    Article  CAS  PubMed  Google Scholar 

  33. Spodick DH. Colchicine therapy of recurrent pericarditis. Circulation. 1991;83(5):1830–1. PubMed.

    CAS  PubMed  Google Scholar 

  34. Millaire A, Ducloux G. Treatment of acute or recurrent pericarditis with colchicine. Circulation. 1991;83(4):1458–9. PubMed.

    CAS  PubMed  Google Scholar 

  35. Adolph RJ. Old drugs with new uses. Colchicine for treatment of recurrent pericarditis. Circulation. 1990;82(4):1505–6. PubMed.

    Article  CAS  PubMed  Google Scholar 

  36. Guindo J, Rodriguez de la Serna A, Ramió J, de Miguel Diaz MA, et al. Recurrent pericarditis. Relief with colchicine. Circulation. 1990;82(4):1117–20.

    Article  CAS  PubMed  Google Scholar 

  37. Lange U, Schumann C, Schmidt KL. Current aspects of colchicine therapy—classical indications and new therapeutic uses. Eur J Med Res. 2001;6(4):150–60.

    CAS  PubMed  Google Scholar 

  38. Imazio M, Brucato A, Trinchero R, Spodick D, Adler Y. Colchicine for pericarditis: hype or hope? Eur Heart J. 2009;30(5):532–9.

    Article  CAS  PubMed  Google Scholar 

  39. Imazio M. Colchicine for pericarditis. Trends in Cardiovasc Med 2014; Oct 2.pii:S 1050-1738(14)00165-0. doi:10.1016/j.tcm.2014.09.011 [Epub ahead of print]. Updated review on the indications, contraindications, precautions, and drug interactions for the safe and efficacious use of colchicine in the setting of pericarditis.

  40. Mayosi BM, Ntsekhe M, Bosch J, et al. IMPI Trial Investigators. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med. 2014;371(12):1121–30. First multicenter RCT on the use of adjunctive therapy with steroids and immunotherapy for probable and definite tuberculous pericarditis.

    Article  CAS  PubMed  Google Scholar 

  41. Alabed S, Cabello JB, Irving GJ, Qintar M, Burls A. Colchicine for pericarditis. Cochrane Database Syst Rev. 2014;8:CD010652.

    PubMed  Google Scholar 

  42. Imazio M, Brucato A, Ferrazzi P, et al. COPPS Investigators. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011;124(21):2290–5. First study to suggest the post-operative use of colchicine for the prevention of post-operative atrial fibrillation (COPPS- substudy).

    Article  CAS  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

None as personal. Unrestricted institutional donation of active drug and placebo was received from Acarpia srl, Madeira, Portugal and institutional funding from FARGIM srl, Catania, Italy to cover insurance costs in order to realize the COPPS-2 trial. Both companies have no role in the planning, performing, analysis, and publication of the trials as well as the present review.

Human and Animal Rights and Informed Consent

All cited clinical trials have been approved by pertinent Ethical Committees and written informed consent obtained by patients. No animal studies are reported in the article.

Author information

Authors and Affiliations

  1. Cardiology Department, Maria Vittoria Hospital and University of Torino, Via Luigi Cibrario 72, 10141, Torino, Italy

    Massimo Imazio

Authors
  1. Massimo Imazio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Massimo Imazio.

Additional information

This article is part of the Topical Collection on Pericardial Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Imazio, M. New Clinical Trials in Acute and Recurrent Pericarditis. Curr Cardiol Rep 17, 23 (2015). https://doi.org/10.1007/s11886-015-0575-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-015-0575-y

Keywords

Search

Navigation